Evidence map›Paper›PMID 35707478›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Effect of Acupressure on Health-Related Quality of Life in Patients with Polycystic Ovarian Syndrome: A Randomized Clinical Trial.

Marzieh Nekooi, Fatemeh Bazarganipour, Mohammad Zoladl, Reza Heshmat, Shahintaj Aramesh, Nazafarin Hosseini

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Marzieh NekooiStudent Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0001-7362-5130
Fatemeh BazarganipourSocial Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0003-4065-7720
Mohammad ZoladlSocial Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0002-9243-0969
Reza HeshmatShahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-7530-3530
Shahintaj ArameshDepartment of Gynecology and Obstetrics, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0003-4979-4385
Nazafarin HosseiniSocial Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0001-7471-7475
Yasuj University of Medical Sciences · IRIranian Orthopedic Association · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was conducted to determine the effect of acupressure on health-related quality of life in patients with polycystic ovary syndrome. This study was a double-blind, randomized clinical trial with a control group. Ninety-six patients with polycystic ovary syndrome from Mofateh gynecological clinic in Yasuj in Iran were enrolled according to the inclusion criteria. Patients were randomly assigned to intervention and control groups. In the intervention group, pressure on the points, Ren3, Ren4, Liv3, Sp6, and Sp10 and in the control group, pressure on sham points were performed for 6 weeks (2 sessions per week). The primary outcome was health-related quality of life, measured by the modified polycystic ovary syndrome health-related quality of life questionnaire (MPCOSQ). The secondary outcomes were total testosterone levels and clinical symptoms in patients with polycystic ovary syndrome. The outcome variables were measured before the intervention at week 0 (baseline) and after the intervention at week 18 (12 weeks after the end of intervention). The results indicated that at week 18, the score of clinical symptoms and the total testosterone level of the intervention group were lower than those of the control group. The health-related quality of life score in the intervention group was higher than that in the control group, which was statistically significant (

Identifiers

PMID35707478
PMCPMC9192291
OpenAlexW4285741771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.